We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Industry

Miraculins Purchases VeraLight’s Noninvasive Diabetes Screening Technology

Miraculins has completed the purchase agreement with VeraLight to acquire all of the relevant assets, including intellectual property, licenses, and regulatory approvals, inventories, data, and marketing materials, relating to VeraLight’s SCOUT DS technology. More...
09 Jul 2013

Mylan's Enhances HIV Care with Distribution Agreement

Mylan has entered into an exclusive agreement with Zyomyx for the rights to distribute Zyomyx's proprietary POC CD4 T-cell count test in the developing world. More...
09 Jul 2013

Pancreatic Cancer to Be Target of Arizona Research Effort

Two US biomedical organizations based in the state of Arizona have agreed to combine their expertise to discover and develop diagnostic markers for detecting and treating cancer. More...
08 Jul 2013

Coalition to Strengthen the Future of Molecular Diagnostics

A diverse group of stakeholders across healthcare industries and patient advocacy organizations has formed a Coalition to Strengthen the Future of Molecular Diagnostics. More...
02 Jul 2013

Seventeen-Year Monopoly on BRCA Testing Ended

Court ruling brings Myriad Genetics' 17-year monopoly on BRCA testing for genetic risk for breast and ovarian cancer to an end. More...
01 Jul 2013

Siemens and Janssen Collaborate on Companion Diagnostic

Siemens Healthcare Diagnostics has entered into a collaboration with Janssen Pharmaceutica NV to design, develop, and commercialize a companion diagnostic test associated with an early-stage compound being developed by Janssen. More...
24 Jun 2013
Image: Mass Spectrometer for Cancer Detection (Photo courtesy of Purdue Research Foundation).

Metabolite Profiling Technology Licensed to Evaluate Cancer Diagnostics

Matrix-Bio has optioned metabolite biomarker technology to evaluate opportunities for new cancer diagnostic tests. More...
24 Jun 2013
New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Portable Electronic Pipette
Mini 96
New
Gel Cards
DG Gel Cards
New
Blood Glucose Test Strip
AutoSense Test


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2025 Globetech Media. All rights reserved.